Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1985-3-1
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0187-4640
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
26
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
331-4
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:6097977-Antiviral Agents,
pubmed-meshheading:6097977-DNA Viruses,
pubmed-meshheading:6097977-Drug Resistance, Microbial,
pubmed-meshheading:6097977-Enterovirus,
pubmed-meshheading:6097977-Nalidixic Acid,
pubmed-meshheading:6097977-Oxolinic Acid,
pubmed-meshheading:6097977-Piromidic Acid
|
| pubmed:articleTitle |
"In vitro" antiviral effects of synthetic compounds upon DNA and RNA viruses.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|